At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions about ...

STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the ...

The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he evade ...

As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and ...

Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors cannot ...

New data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds ...

The effects of isolation extend far beyond children’s time in the hospital,” writes medical student Anna Tsioulias.

Here are some things STAT will be watching for during Wednesday’s hearing: Health secretary Robert F. Kennedy Jr. and Paul ...

A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the U.S.

ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on ...

Growing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...